Clinical Trial Update: Efficacy and Safety Study of Aripiprazole to Treat Schizophrenia [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the efficacy and safety of aripiprazole for schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Otsuka Beijing Research Institute | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED